A comparative Bioavailability study in Healthy Subjects

Not Applicable

• Registration Number: CTRI/2022/02/039882
• Lead Sponsor: Vidya Herbs Pvt Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 February 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Subjects who are willing to give their written informed consent and comply with the protocol requirements.

2.Females of child bearing age, agree to use approved birth control methods during the study, and have negative urine pregnancy test (UPT) at screening

3.Subject understands the study procedures, is ready to comply and provide signed informed consent form (ICF) to participate in the study

Exclusion Criteria

1.Subjects who have consumed curcumin (turmeric) containing food 2 days prior to screening

2.Subjects having symptoms of viral infection, including COVID-19 infection

3.Pregnant or lactating women.

4.Subjects with known hypersensitivity to the investigational products.

5.Subjects who have participated in any clinical trial in the past 1 month.

6.Any subjects found to have entered in to the study in violation of this protocol or if the subject is uncooperative during the study.

7.Any other condition that in the opinion of the investigator that does not justify the subjectâ??s participation in the trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assess the bioavailability of curcuminoids formulation, Vicumin in comparison with AcuminTimepoint: Day 1(Period 1), Day 11(Period 2)

Secondary Outcome Measures

Name	Time	Method
Safety of Curcuminioids formulations Vicumin and AcuminTimepoint: Day 1(Period 1), Day 11(Period 2)